循环二甲酶3通过 ангиотензин的裂变调节系统和脏血动力学
Adrien Picod1, Sandrine Placier2, Magali Genest1
1Institut National de la Santé et de la Recherche Médicale UMR-S 942 MASCOT - Paris - Cité University, Paris, France (A.P., M.G., J.C., N.J., M.Z., N.A., H.N., A.M., F.A.).
Hypertension (Dallas, Tex. : 1979)
|February 9, 2024
概括
高水平的二二甲酶3 (DPP3) 通过降低血管激素II受体激活来增加脏血流. 这种效应通过释放甲醇胺来平衡,在危急病患者中维持血压.
科学领域:
- 心血管生理学心血管生理学
- 脏生理学 脏生理学
- 临界护理医学 临界护理医学
背景情况:
- 提升的二乙酶3 (DPP3) 与血液循环衰竭的重症患者的不良结果相关.
- DPP3可能会通过过度裂解血管酶产生病理效应.
- 研究DPP3在血液动力学和氨酸 - 血管新生素系统中的作用至关重要.
研究的目的:
- 在小鼠模型中检查DPP3的血液动力学效应.
- 阐明DPP3活性与氨酸-血管酶系统调节之间的关系.
- 了解DPP3引起的循环变化背后的机制.
主要方法:
- 在C57Bl/6J小鼠中静脉注射净化的人类DPP3或抗DPP3抗体 (普罗齐祖马布).
- 对血压和脏血流的侵入性监测.
- 通过受体阻塞实验,测量循环中的血管素和甲基荷兰胺.
主要成果:
- DPP3的使用显著增加了脏血液流动;血压基本保持不变.
- 普罗齐祖马布的使用导致脏血液流量显著下降.
- DPP3的血管效应归因于AT1R激活的减少,而AT1R激活源于血管酶II,III和IV水平的降低.
- 同时释放的甲基荷胺解释了在DPP3服药期间的血压维持.
结论:
- 高循环的DPP3通过降低血管新生素II受体1型 (AT1R) 激活通过降低血管新生素度来提高脏血液流动.
- 同时释放的内源性甲醇胺维持血压,尽管DPP3诱导的血液动力学变化.
- DPP3通过renin-angiotensin和catecholamine系统中的复杂相互作用影响动力学和血压调节.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
640
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
640
01:25Antihypertensive Drugs: Direct Renin Inhibitors
629
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
629
01:33Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
01:17Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K